FI954245A - Compositions and methods for treating immune-mediated inflammatory disorders - Google Patents

Compositions and methods for treating immune-mediated inflammatory disorders Download PDF

Info

Publication number
FI954245A
FI954245A FI954245A FI954245A FI954245A FI 954245 A FI954245 A FI 954245A FI 954245 A FI954245 A FI 954245A FI 954245 A FI954245 A FI 954245A FI 954245 A FI954245 A FI 954245A
Authority
FI
Finland
Prior art keywords
compositions
methods
inflammatory disorders
mediated inflammatory
treating immune
Prior art date
Application number
FI954245A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI954245A0 (en
Inventor
Kerry Spear
Charles Johnson
Heinz W Gschwend
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of FI954245A0 publication Critical patent/FI954245A0/en
Publication of FI954245A publication Critical patent/FI954245A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FI954245A 1993-03-12 1995-09-11 Compositions and methods for treating immune-mediated inflammatory disorders FI954245A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3077093A 1993-03-12 1993-03-12
US3118793A 1993-03-12 1993-03-12
PCT/US1994/002706 WO1994020527A1 (en) 1993-03-12 1994-03-11 Compositions and methods for the treatment of immunomediated inflammatory disorders

Publications (2)

Publication Number Publication Date
FI954245A0 FI954245A0 (en) 1995-09-11
FI954245A true FI954245A (en) 1995-09-28

Family

ID=26706445

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954245A FI954245A (en) 1993-03-12 1995-09-11 Compositions and methods for treating immune-mediated inflammatory disorders

Country Status (11)

Country Link
EP (1) EP0688337A1 (en)
JP (1) JPH08507768A (en)
KR (1) KR100309616B1 (en)
CN (2) CN1057772C (en)
AU (1) AU683459B2 (en)
CZ (1) CZ289930B6 (en)
FI (1) FI954245A (en)
PL (1) PL176941B1 (en)
SK (1) SK282537B6 (en)
UA (1) UA42719C2 (en)
WO (1) WO1994020527A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0763016B1 (en) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Compositions and methods for treating mast-cell mediated conditions
JPH10506390A (en) 1994-09-23 1998-06-23 アリス ファーマシューティカル コーポレイション Compositions and methods for treating mast cell inflammatory conditions
WO1997037969A1 (en) 1996-04-10 1997-10-16 Ono Pharmaceutical Co., Ltd. Tryptase inhibitor and novel guanidino derivatives
HUP0003267A3 (en) * 1996-07-30 2002-02-28 Arris Pharmaceutical Corp San Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them
WO1998024886A1 (en) * 1996-12-04 1998-06-11 Brigham And Women's Hospital, Inc. Mast cell protease that cleaves fibrinogen
WO1998033812A1 (en) * 1997-02-05 1998-08-06 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
EP1030844A1 (en) * 1997-11-10 2000-08-30 Array Biopharma Inc. Compounds which inhibit tryptase activity
US6221914B1 (en) * 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
WO1999026925A1 (en) * 1997-11-26 1999-06-03 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
SE9800729L (en) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab New topical formulation I
SE515982C2 (en) * 1998-03-06 2001-11-05 Lipocore Holding Ab Use of an oil-in-water emulsion as carrier for preparing a topical cream or lotion
DE19939910A1 (en) * 1999-08-23 2001-03-01 Morphochem Ag New compounds that inhibit tryptase activity
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201863A (en) * 1974-11-08 1980-05-06 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4456595A (en) * 1982-12-06 1984-06-26 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy aroly peptides

Also Published As

Publication number Publication date
SK282537B6 (en) 2002-10-08
AU6364794A (en) 1994-09-26
AU683459B2 (en) 1997-11-13
UA42719C2 (en) 2001-11-15
KR100309616B1 (en) 2002-02-28
EP0688337A1 (en) 1995-12-27
SK112995A3 (en) 1996-10-02
PL310559A1 (en) 1995-12-27
JPH08507768A (en) 1996-08-20
WO1994020527A1 (en) 1994-09-15
CN1057772C (en) 2000-10-25
CZ232195A3 (en) 1996-07-17
CZ289930B6 (en) 2002-04-17
PL176941B1 (en) 1999-08-31
FI954245A0 (en) 1995-09-11
CN1234229A (en) 1999-11-10
CN1119019A (en) 1996-03-20

Similar Documents

Publication Publication Date Title
KR950700732A (en) Compounds useful for treating allergic and inflammatory diseases
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
DE69325158D1 (en) Photocromic composition
EE9700089A (en) Compositions and methods for treating mast cell mediated inflammatory conditions
DE69327741D1 (en) Photopolymerizable composition
BR9403946A (en) Composition of matter
DE69526966D1 (en) SKIN-STRENGTHING COMETIC COMPOSITION
BR9509200A (en) Composition of matter
FI951197A (en) Microbicidal compositions and methods
DK0565078T3 (en) Hardenable composition
IS4466A (en) Composition and treatment for multiple sclerosis
FI954773A0 (en) Anti-hypertriglyceridemia composition
FI954245A (en) Compositions and methods for treating immune-mediated inflammatory disorders
DE69320397T2 (en) Photopolymerizable composition
FI965008A0 (en) Compositions and methods for treating tumors
DE69520998D1 (en) Fiber treatment compositions
DE69413610D1 (en) Particle cement compositions
FI955123A (en) Cholestyramine-containing composition and method for its preparation
DE69332687D1 (en) PHOTOPOLYMERIZABLE COMPOSITION
FI970657A0 (en) Compositions and methods for controlling pests
DE69217904T2 (en) composition
FR2723123B1 (en) 120 MINUTES FIRE-RESISTANT GLASS FLOORING
FI934360A (en) SYNERGISTIC ANTIMALAR COMPOSITION INNEHAOLLANDE BENFLUMETOL